James J. Dignam to Angiogenesis Inhibitors
This is a "connection" page, showing publications James J. Dignam has written about Angiogenesis Inhibitors.
Connection Strength
0.113
-
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014 Feb 20; 370(8):699-708.
Score: 0.100
-
Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J Magn Reson Imaging. 2004 Jul; 20(1):122-8.
Score: 0.013